Israel - English - Ministry of Health

nutrition consumer health - diclofenac as potassium - film coated tablets - diclofenac as potassium 12.5 mg - diclofenac - diclofenac - short term analgesic and antipyretic in adults for a maximum of 3 days treatment for the relief of headache dental pain backache , period pain, rhematic and muscular pain, and fever reduction.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - paroxetine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets, usp in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology —clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets, usp in hospitalized depressed patients have not been adequately studie

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - methocarbamol (unii: 125od7737x) (methocarbamol - unii:125od7737x) - methocarbamol 500 mg - methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. methocarbamol does not directly relax tense skeletal muscles in man. methocarbamol is contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 10 mg - methylphenidate hydrochloride extended-release capsules are indicated for the treatment of attention deficit hyperactivity disorder (adhd) in pediatric patients 6 to 15 years of age. methylphenidate hydrochloride extended-release capsules are contraindicated in patients with: - known hypersensitivity to methylphenidate or other component of methylphenidate hydrochloride extended-release capsules. angioedema has been reported in patients treated with methylphenidate hydrochloride extended-release capsules. anaphylactic reactions have been reported in patients treated with other methylphenidate products [see adverse reactions (6)] . - concomitant treatment with monoamine oxidase inhibitors (maois), or within 14 days following discontinuation of treatment with an maoi, because of the risk of hypertensive crisis [see drug interactions (7)] . - methylphenidate hydrochloride extended-release capsules contain sucrose. therefore, patients with hereditary problems of fructose intolerance, glucose-galactose malabsorpti

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine extended-release tablets are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablets may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion, or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta blockers. nifedipine extended-release tablets are indicated for the management of chron

United States - English - NLM (National Library of Medicine)

chattem, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - topical anesthetic topical analgesic temporarily relieves minor pain

United States - English - NLM (National Library of Medicine)

conopco inc. d/b/a/ unilever - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria on the skin. recommended for repeated use

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin is indicated for:  • management of neuropathic pain associated with diabetic peripheral neuropathy  • management of postherpetic neuralgia  • adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • management of fibromyalgia • management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral solution products. however, due to pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)].  pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information re

United States - English - NLM (National Library of Medicine)

almark products inc - camphor 3.00% menthol 2.00%, pain reliever - for temporary relief of minor aches and pains of muscles and joints: • arthritis • simple backaches • soreness • strains • sprains • bruises